Abstract
The β-carboline ZK 93 426, a benzodiazepine receptor antagonist, was administered intravenously to human volunteers at two different doses (0.01 mg/kg, 0.04 mg/kg) according to a double-blind, placebo controlled design. Vital functions (i.e. blood pressure, heart rate, ECG, EEG), peripheral (finger) skin temperature and performance in psychometric tests for psychotropic and cognitive effects were evaluated. Blood samples were collected in addition and certain pharmacokinetic parameters were estimated. ZK 93 426 in both doses was well tolerated and exhibited no side effects. A decrease in peripheral skin temperature and heart rate was observed. In a general estimation of behavioural changes, volunteers experienced a stimulant and activating effect of the drug. An improvement in performance was observed in two cognitive tasks, the “logical reasoning task” and “pictures differences task” which estimated concentration and attention, respectively. No effects were found in time estimation. Plasma levels 5 min after intravenous administration of ZK 93 426 were 16±10 ng/ml and 52±31 ng/ml for 0.01 mg/kg and 0.04 mg/kg, respectively. Total clearance was calculated as 46±22 ml/min/kg (0.04 mg/kg).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baddeley AD (1968) A 3-min reasoning test based on grammatical transformation. Psychon Sci 10:341–342
Bernard P, Bergen K, Sobiski R, Robson RD (1981) CGS 8216 (2-Phenylpyrazolo(4,3-c)quinoline-3(5H)-one), an orally effective benzodiazepine antagonist. Pharmacologist 23:150–156
Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, Müller RKM, Haefely W (1982) Benzodiazepine antagonist Ro 15–1788: Neurological and behavioural effects. Psychopharmacology 78:8–18
Braestrup C, Schmiechen R, Neff G, Nielsen M, Petersen EN (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241–1243
Brosan L, Broadbent D, Nutt D, Broadbent M (1986) Performance effects of diazepam during and after prolonged administration. Psychol Med 16:510–522
Czernik AJ, Petrack B, Kalinsky HJ, Psychoyos S, Cash WD, Tsai C, Rinehart RK, Granat FR, Lovell RA, Brundish DE, Wade R (1982) CGS 8216: Receptor binding characteristics of a potent benzodiazepine antagonist. Life Sci 30:363–372
Dantzer R, Perio A (1982) Behavioural evidence for partial agonist properties of Ro 15–1788, a benzodiazepine receptor antagonist. Eur J Pharmacol 81:655–658
Dorow R, Duka T (1986) Anxiety: Its generation by drugs and by their withdrawal. In: Biggio G, Costa E (eds) GABAergic transmission and anxiety. Raven, New York, pp 221–225
Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C (1983) Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors. Lancet II:98
Dorow R, Berenberg D, Duka T, Sauerbrey N (1987) Reversal of benzodiazepine-induced amnesia by the benzodiazepine antagonist Ro 15–1788. In: Hindmarsh I, Ott H, Roth T (eds) Benzodiazepine receptor ligand; memory and information processing. Psychopharmacology Supp., Springer, New York Berlin Heidelberg (in press)
Duka T, Ackenheil M, Noderer J, Doenicke A, Dorow R (1986a) Changes in Noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15–1788. Psychopharmacology 90:351–357
Duka T, Höller L, Oben-Gyan R, Dorow R (1986b) Initial human pharmacology of the neutral benzodiazepine receptor antagonist β-carboline ZK 93 426. Br J Clin Pharmacol 22:228
Elsass P, Mellerup ET, Rafaelsen OJ, Theilgaard A (1979) Lithium effects on time estimation and mood in manic-melancholic patients. A study of diurnal variations. Acta Psychiatr Scand 60:263–271
Emrich HM, Sonderegger P, Mai N (1984) Action of the benzodiazepine antagonist Ro 15–1788 in humans after sleep withdrawal. Neurosci Lett 47:369–373
File SE, Lister RG, Nutt D (1982) Intrinsic actions of benzodiazepine antagonists. Neurosci Lett 32:165–168
File SE, Pellow S, Jensen LH (1986) Actions of the β-carboline ZK 93 426 in animal test of anxiety and the holebord: Interactions with Ro 15–1788. J Neural Transm 65:103–114
Galster JW, Spörl G (1979) Entwicklung einer Skala zur Quantifizierung transitorischer und habitueller Angstzustände. Neurolog Psychiatr 5:223–226
Guy W (1973) Guide to the New ECDEU Assessment Battery. ECDEU Intecome 3, 1:43–52
Hunkeler W, Möhler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:514–516
Jensen LH, Petersen EN, Braestrup C, Honoré T, Kehr W, Stephens DN, Schneider H, Seidelmann D, Schmiechen R (1984) Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist. Psychopharmacology 83:249–256
Jensen LH, Petersen EN, Honoré T, Drejer J (1986) Bidirectional modulation of GABA function by β-carbolines. In: Biggio G, Costa E (eds) GABAergic transmission and anxiety. Raven, New York, pp 79–89
Möhler H, Okada T (1977) Benzodiazepine receptors: demonstration in the CNS. Science 198:849–851
Nutt DJ, Cowen PJ, Little HJ (1982) Unusual interactions of benzodiazepine receptor antagonist. Nature 295:436–438
Pellow S, File SE (1986) Intrinsic actions of the benzodiazepine receptor antagonist Ro 15–1788. Psychopharmacology 88:1–11
Petersen EN (1983) DMCM: A potent convulsive benzodiazepine receptor ligand. Eur J Pharmacol 94:117–124
Petersen EN, Paschelke G, Kehr W, Nielsen M, Braestrup C (1982) Does the reversal of the anticonflict effect of phenobarbital by β-CCE and FG 7142 indicate benzodiazepine receptor mediated anxiogenic properties? Eur J Pharmacol 82:117–124
Polc P, Laurent JP, Scherschlicht R, Haefely W (1981) Electrophysiological studies on the specific benzodiazepine antagonist Ro 15–1788. Naunyn-Schmiedeberg's Arch Pharmacol 321:260–264
Sarter M, Stephens DN (1987) β-carbolines as tools in memory research. Animal data and speculations. In: Hindmarsh I, Ott H, Roth T (eds) Benzodiazepine receptor ligands. Memory and information processing. Psychopharmacology Supp. Springer, New York Berlin Heidelberg (in press)
Schöpf J, Laurian S, Le PK, Gaillard JM (1984) Intrinsic activity of the benzodiazepine antagonist Ro 15–1788 in man: an electrophysiological investigation. Pharmacopsychiatry 17:79–83
Squires RF, Braestrup C (1977) Benzodiazepine receptors in rat in brain. Nature 266:732–734
Stephens DN, Kehr W (1985) β-carbolines can enhance or antagonize the effects of propunishment in mice. Psychopharmacology 85:143–147
Stephens DN, Sarter M (1987) Bidirectional nature of benzodiazepine receptor ligands extend to effects on vigilance. In: Hindmarsh I, Ott H, Roth T (eds) Benzodiazepine receptor ligands, memory and information processing. Psychopharmacology Supp. Springer, New York Berlin Heidelberg (in press)
Stephens DN, Shearman GT, Kehr W (1984) Discriminative stimulus properties of β-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors. Psychopharmacology 83:233–239
Stephens DN, Kehr W, Duka T (1986) Anxiolytic and anxiogenic β-carbolines: Tools for the study of anxiety mechanisms. In: Biggio G, Costa E (eds) GABAergic transmission and anxiety. Raven, New York
Venault P, Chapoutier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks. Nature 321:864–866
Ziegler G, Ludwig L, Fritz G (1986) Effects on the specific benzodiazepine antagonist Ro 15–1788 on sleep. Pharmacopsychiatry 19:200–201
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duka, T., Stephens, D.N., Krause, W. et al. Human studies on the benzodiazepine receptor antagonist β-carboline ZK 93 426: preliminary observations on psychotropic activity. Psychopharmacology 93, 421–427 (1987). https://doi.org/10.1007/BF00207229
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00207229